225 related articles for article (PubMed ID: 33512523)
1. National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States.
Nelson RE; Hatfield KM; Wolford H; Samore MH; Scott RD; Reddy SC; Olubajo B; Paul P; Jernigan JA; Baggs J
Clin Infect Dis; 2021 Jan; 72(Suppl 1):S17-S26. PubMed ID: 33512523
[TBL] [Abstract][Full Text] [Related]
2. Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States.
Nelson RE; Hyun D; Jezek A; Samore MH
Clin Infect Dis; 2022 Mar; 74(6):1070-1080. PubMed ID: 34617118
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017.
Jernigan JA; Hatfield KM; Wolford H; Nelson RE; Olubajo B; Reddy SC; McCarthy N; Paul P; McDonald LC; Kallen A; Fiore A; Craig M; Baggs J
N Engl J Med; 2020 Apr; 382(14):1309-1319. PubMed ID: 32242356
[TBL] [Abstract][Full Text] [Related]
4. Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus.
Nelson RE; Slayton RB; Stevens VW; Jones MM; Khader K; Rubin MA; Jernigan JA; Samore MH
Infect Control Hosp Epidemiol; 2017 Jul; 38(7):848-856. PubMed ID: 28566096
[TBL] [Abstract][Full Text] [Related]
5. The impact of healthcare-associated methicillin-resistant Staphylococcus aureus infections on post-discharge healthcare costs and utilization.
Nelson RE; Jones M; Liu CF; Samore MH; Evans ME; Graves N; Lee B; Rubin MA
Infect Control Hosp Epidemiol; 2015 May; 36(5):534-42. PubMed ID: 25715806
[TBL] [Abstract][Full Text] [Related]
6. Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence.
Tansarli GS; Karageorgopoulos DE; Kapaskelis A; Falagas ME
Expert Rev Anti Infect Ther; 2013 Mar; 11(3):321-31. PubMed ID: 23458771
[TBL] [Abstract][Full Text] [Related]
7. Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada.
Kirwin E; Varughese M; Waldner D; Simmonds K; Joffe AM; Smith S
BMC Health Serv Res; 2019 Oct; 19(1):743. PubMed ID: 31651305
[TBL] [Abstract][Full Text] [Related]
8. Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections.
Nelson RE; Schweizer ML; Perencevich EN; Nelson SD; Khader K; Chiang HY; Chorazy ML; Blevins A; Ward MA; Samore MH
Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1212-8. PubMed ID: 27406609
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, Resistance Profiles, and Outcomes of Bloodstream Infections in Community-Onset Sepsis in the United States.
Ohnuma T; Chihara S; Costin B; Treggiari M; Bartz RR; Raghunathan K; Krishnamoorthy V
Crit Care Med; 2023 Sep; 51(9):1148-1158. PubMed ID: 37276351
[TBL] [Abstract][Full Text] [Related]
10. The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting-A national estimate.
Johnston KJ; Thorpe KE; Jacob JT; Murphy DJ
Health Serv Res; 2019 Aug; 54(4):782-792. PubMed ID: 30864179
[TBL] [Abstract][Full Text] [Related]
11. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.
Hidron AI; Edwards JR; Patel J; Horan TC; Sievert DM; Pollock DA; Fridkin SK; ;
Infect Control Hosp Epidemiol; 2008 Nov; 29(11):996-1011. PubMed ID: 18947320
[TBL] [Abstract][Full Text] [Related]
12. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.
Polly M; de Almeida BL; Lennon RP; Cortês MF; Costa SF; Guimarães T
Am J Infect Control; 2022 Jan; 50(1):32-38. PubMed ID: 34562526
[TBL] [Abstract][Full Text] [Related]
13. Attributable Cost of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infection in a Long-term Care Center.
Nelson RE; Lautenbach E; Chang N; Jones M; Willson T; David M; Linkin D; Glick H; Doshi JA; Stevens VW
Clin Infect Dis; 2021 Jan; 72(Suppl 1):S27-S33. PubMed ID: 33512522
[TBL] [Abstract][Full Text] [Related]
14. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.
Filice GA; Nyman JA; Lexau C; Lees CH; Bockstedt LA; Como-Sabetti K; Lesher LJ; Lynfield R
Infect Control Hosp Epidemiol; 2010 Apr; 31(4):365-73. PubMed ID: 20184420
[TBL] [Abstract][Full Text] [Related]
15. Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.
Giraldi G; Montesano M; Napoli C; Frati P; La Russa R; Santurro A; Scopetti M; Orsi GB
Curr Pharm Biotechnol; 2019; 20(8):643-652. PubMed ID: 30961489
[TBL] [Abstract][Full Text] [Related]
16. The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective.
Iskandar K; Roques C; Hallit S; Husni-Samaha R; Dirani N; Rizk R; Abdo R; Yared Y; Matta M; Mostafa I; Matta R; Salameh P; Molinier L
BMC Infect Dis; 2021 May; 21(1):404. PubMed ID: 33933013
[TBL] [Abstract][Full Text] [Related]
17. Reducing Time-dependent Bias in Estimates of the Attributable Cost of Health Care-associated Methicillin-resistant Staphylococcus aureus Infections: A Comparison of Three Estimation Strategies.
Nelson RE; Samore MH; Jones M; Greene T; Stevens VW; Liu CF; Graves N; Evans MF; Rubin MA
Med Care; 2015 Sep; 53(9):827-34. PubMed ID: 26225444
[TBL] [Abstract][Full Text] [Related]
18. Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
Balkhy HH; El-Saed A; Alshamrani MM; Alsaedi A; Al Nasser W; El Gammal A; Aljohany SM; Almunif S; Arabi Y; Alqahtani S; Bonnie HB; Alghoribi M; Alothman A; Almohrij SA
Antimicrob Resist Infect Control; 2020 Jan; 9(1):21. PubMed ID: 32000850
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
Litwin A; Fedorowicz O; Duszynska W
Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
[No Abstract] [Full Text] [Related]
20. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.
Weiner LM; Fridkin SK; Aponte-Torres Z; Avery L; Coffin N; Dudeck MA; Edwards JR; Jernigan JA; Konnor R; Soe MM; Peterson K; McDonald LC
MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(9):235-41. PubMed ID: 26963489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
